Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Scientist II at Editas Medicine
Terence Ta is a Scientist in the Platform group at Editas Medicine and is responsible for reagent QA/QC and development of analytics for research. Prior to joining Editas, Terence was an Investigator in the Drug Product Formulations group at GSK Vaccines, where he developed quality assays for the company’s mRNA platform and performed formulation development for its adjuvant and vaccine programs in preclinical development. He was also an early scientist at HelixBind, a molecular diagnostics company focusing on commercialization of devices for the rapid identification of infectious pathogens to improve sepsis outcomes. Terence received a B.S. in Chemical Engineering from the Massachusetts Institute of Technology and a Ph.D. in Biomedical Engineering from Boston University.